1. The adrenal response to a reduction in extracellular fluid volume (ECFV), sodium depletion, intravenous adrenocorticotrophic hormone (ACTH) and angiotensin I1 was assessed from changes in plasma aldosterone and plasma cortisol in eleven nephrectomized patients. Five patients were also studied before nephrectomy and six after successful renal transplantation.
of sodium and potassium (Blair West, Coghlan, Denton, Goding, Munro, Peterson & Wintour, 1962; Davis, Urquhart & Higgins, I963) , adrenocorticotrophic hormone (ACTH) (Farrell, Rauschkolb & Royce, 1955; Liddle, Duncan & Bartter, 1956 ) and the renin-angiotensin system (Deane & Masson, 1951 ; Gross, 1958; Laragh, 1960; Genest, Nowaczynski, Koiw, Sandor & Biron, 1960) .
However, more recently there has been some doubt as to whether the renin-angiotensin system is the primary controlling factor for aldosterone (Boyd, Adamson, Arnold, James & Peart, 1972 ). Considerable differences have been shown between species, in particular the rat (Palmore, Marieb & Mulrow, 1969) , and the hypophysectomized dog and sheep (Davis, 1961 ; Ganong & Mulrow, 1961 ; Blair West, Coghlan, Denton, Goding, Wintour & Wright, 1968) . Similar difficulties of interpretation have arisen from work in the sodium-depleted sheep (Blair West et al., 1962; Blair West, Coghlan, Cain, Catt, Denton, Funder, Scoggins & Wright, 1971) and in the rabbit immunized against angiotensin 11, where aldosterone may still increase after sodium depletion (Lowenstein, Boyd, Rippon, James & Peart, 1972) . A number of clinical situations in man are also known where levels of plasma renin and aldosterone have been shown to move in opposite directions (Slater, Tuffley, Edwards, Ekins, Beresford, Sonksen, Williams & McLaughlin, 1969; Veyrat, Brunner, Manning & Muller, 1967; Chinn, Brown, Fraser, Heron, Lever, Murchison & Robertson, 1970) .
The present study was designed to examine the part played by the renin-angiotensin system in the control of aldosterone before and after nephrectomy, and after renal transplantation.
M A T E R I A L S A N D M E T H O D S
Eleven patients were studied, all of whom were awaiting renal transplantation. All eleven patients were studied after nephrectomy, but five of these patients were also studied before nephrectomy. The informed consent of the patients was obtained and permission for the study was obtained from the local ethical research committee. Eight of the patients were maintained on peritoneal dialysis and the other three were on intermittent haemodialysis. Table I gives details of the patients, including their age, sex, original disease, blood pressure when first admitted, date of starting dialysis, the type of dialysis and the date of nephrectomy.
Peritoneal dialysis was performed nightly in the standard way using six 2-litre exchanges or until about 1500 ml of peritoneal dialysate had been removed. Isotonic low-sodium dialysis fluid [68*5 mmol/l (1.36%) dextrose, Allen and Hanburys no. 631 was used in conjunction with hypertonic fluid [321 mmol/l (6.36%) dextrose, Allen and Hanburys no. 621. Heparin (1000 units) was added to each bag. No additional potassium was used. Intermittent haemodialysis was performed twice a week with a Dylade or Lucas machine and either a Baxter's minicoil or Kiil dialyser. Heparin infusion was at a rate of 1335 units/h. Expt. 1 : change in plasma aldosterone (aldosterone response) to a reduction in ECFV and after sodium depletion
In this group five patients were studied. Two of these were also studied before nephrectomy. All these patients had been maintained on peritoneal dialysis for from 21 to 390 days (mean 141 days). The total volume of fluid removed ranged from 1120 to 2860 (mean 1956) ml. The total amount of sodium removed at each dialysis was measured and ranged from 148 to 340 (mean 237) mmol. Blood samples for sodium and potassium, plasma aldosterone and plasma cortisol were taken before dialysis through an indwelling cannula after the patient had been recumbent for 1 h, and again 1 h after the end of dialysis.
Expt. 2 : response of the adrenal gland (change in plasma aldosterone and cortisol) to intravenous
ACTH
In this group, seven patients were studied, five before and after nephrectomy and two only after nephrectomy. After the patient had been recumbent for 1 h, blood samples were drawn through an indwelling cannula for analysis of plasma sodium, potassium, aldosterone and cortisol. ACTH (Organon; 75 units) was then given intravenously by a bolus injection and further blood samples were taken as above at the end of 1 h. This experiment was carried out 1 h after the end of dialysis. Three of the patients (B.P., W.H. and J.S.) were on haemodialysis. Expt. 3 : response of the adrenal gland (change in plasma aldosterone and cortisol) to intravenous angiotensin II In this group, five patients were studied before nephrectomy and ten after nephrectomy. Of the ten studied after nephrectomy, three were maintained on haemodialysis. A standard infusion of angiotensin I1 (Hypertensin-Ciba) was used at a rate of 0.49 nmol (0-5 pg) min-l. Blood samples were taken as in Expt. 2 after 1 h of recumbency and before the infusion was started. The infusion was continued for 3 h and, while still running, taking of blood samples was repeated. The blood pressure was taken during the infusion at 5 min intervals until a steady pressure was maintained, and thereafter every 10 min. The patient was recumbent and the pressure was taken with a standard sphygmomanometer and the change (pressor response) recorded. Expt. 4 : adrenal response (plasma aldosterone and plasma cortisol) after renal transplantation In this group six patients were studied after intravenous ACTH and four patients after angiotensin 11.
Laboratory methods
Electrolyte concentrations were measured by AutoAnalyzer, plasma aldosterone by the method of Mayes, Furuyama, Kem & Nugent (1970) and plasma cortisol as described by Townsend & James (1968) . Plasma renin activity was measured in three patients only (M.T., W.H. and B.P.) before and after nephrectomy.
R E S U L T S
Response to dialysis (reduction in ECFV and sodium depletion) Table 2 shows the results obtained (a) before and (b) after peritoneal dialysis in five nephrectomized patients. The time after nephrectomy is also indicated in days.
The resting level of plasma aldosterone is uniformly undetectable [normal range 5-22 pmol/ 100 ml (1.8-7.8 ng/100 ml)] and the response to sodium and ECFV depletion is very poor or non-existent. The plasma cortisol level shows a small shift after dialysis in the three patients in whom it was measured. There is little change in plasma electrolytes across dialysis and there is no difference in response whether potassium levels are either high or normal. Table 3 shows the results in two patients before nephrectomy. The data available are limited but the resting levels are either well within or above the normal range and the one response recorded is extremely high. After nephrectorny both these patients show plasma aldosterone levels that are undetectable at rest and there is no response after dialysis. Table 4 shows the results in those patients who had undergone nephrectomy and who were given a standard infusion of angiotensin 11. The systolic pressure rise ranged from 10 to 80 mmHg (mean 28 mmHg) and the diastolic pressure rise from 5 to 35 mmHg (mean 19 mmHg).
Response to angiotensin infusion
The adrenal response to angiotensin infusion is generally very poor. Three results, however, stand out from the rest. Two patients (M.T. and W.H.) were studied at various intervals after nephrectomy. M.T. was followed at 5, 13 and 26 days after nephrectomy and undoubtedly the adrenal response shows a falling off over this period. W.H. was followed up to 62 days after nephrectomy, but exhibited no response as early as 7 days. The third patient (J.S.) shows a response that is at the lower limit of the normal range [normal range 5-22 (mean 11) pmo1/100 ml, rising to a mean of 67 pmo1/100 ml, range 25-106 (Boyd, Adamson, James & Peart, 1969) l. This patient has been maintained on haemodialysis for 9 months; this represents almost the longest period studied after nephrectomy and during dialysis, a factor which may be important. Four of these last group of patients were also studied in the same way before nephrectomy (Table 5 ). In this group all patients have a high resting plasma aldosterone and in two instances there was an increase after angiotensin infusion.
Response to intravenous ACTH
The results for those patients given intravenous ACTH both before and after nephrectomy are shown in Tables 6 and 7. The cortisol response is normal in all cases except one (B.P.), who was being treated with prednisone at the time. That there is a rise in plasma aldosterone after intravenous ACTH is clearly shown and this is more marked than with angiotensin before nephrectomy (cf. Tables 5 and 6). After nephrectomy the response is very poor. Again, the decline with time after nephrectomy of the response in one patient (M.T.) is well demonstrated (Table 7 and Fig. I) . Although the responses after ACTH are still poor, in three instances (W.H., M.T. and J.S.) the response is rather better than that seen after angiotensin infusion (cf. Tables 4 and 7). Response after renal transplantation Six patients were studied again after successful renal transplantation These patients were being maintained on a standard regime of immunosuppressive therapy with prednisone (1 5 mg daily) and azathioprine (3 mg/kg body weight). Table 8 shows the plasma aldosterone and cortisol responses after intravenous ACTH. Without exception the aldosterone response has returned to within the normal range, 22-70 pmo1/100 ml (V. H. T. James, unpublished data), but the cortisol response is greatly diminished. The time factor after transplantation is variable and in all but one patient (S.V.) renal function is exceptionally good. Table 9 shows the plasma aldosterone response in four patients only after infusion of angiotensin IT. The response has once again reverted to the normal range (see above). Fig. 1 shows the full study in one patient (M.T.), who was studied across nephrectomy and at varying intervals after nephrectomy and after transplantation. The high levels of aldosterone and responses to ACTH and angiotensin TI fall away after nephrectomy and are within the normal range after transplantation. This patient had the lowest response of all patients after transplantation although still within the normal range. Finally Fig. 2 summarizes the pattern of responses seen before nephrectomy, after nephrectomy and after transplantation. Once again the high resting plasma aldosterone and variable responses to ACTH and angiotensin I1 are seen before nephrectomy, together with the uniformly poor response after nephrectomy. The change to a normal response after transplantation is clearly shown. 
DISCUSSION
The role of the renin-angiotensin system in the control of aldosterone has been studied in patients who have undergone nephrectomy and who have been maintained in a relatively fit condition by peritoneal and haemodialysis. In certain instances the patients were studied before nephrectomy as well, and the most striking feature to emerge from the study is the fact that the response of the zona glomerulosa of the adrenal gland is considerably altered once the kidney has been removed. Thus the response to the usual well-recognized stimuli of sodium deprivation, ACTH and angiotensin is no longer as marked, although the plasma cortisol response to ACTH has been well maintained. These data appear to implicate the kidney in the control of aldosterone secretion. The evidence is strengthened by the studies on those patients who showed negligible or very poor responses before transplantation and who were transplanted subsequently. In these patients, without exception, the aldosterone response to angiotensin I1 and ACTH returned to normal. This response was selective for aldosterone since as would be expected the cortisol response is depressed by prednisone therapy after transplantation. All the patients who received grafts except one had excellent renal function, but it seems probable that it is the presence of the kidney alone rather than a kidney with good excretory function that is important. All the patients studied before nephrectomy were in terminal renal failure and it is in these patients that the highest levels of plasma aldosterone were recorded. This would suggest that failure of excretory function is not the important factor in the reduced adrenal response after nephrectomy.
The regulation of aldosterone in nephrectomized man has become the subject of increasing study (Bayard, Weidmann, Horton, Maxwell, Franklin & Fichman, 1973) . Various hypotheses, however, have been put forward for the regulation of aldosterone in the nephrectomized state. The above workers have to some extent found different responses with similar stimuli. A recent report (McCaa, McCaa, Read & Bower, 1972b) showed that haemodialysis can acutely stimulate aldosterone secretion in nephrectomized man and suggested that this is not mediated through the renin-angiotensin system, ACTH or changes in the plasma potassium. These workers found that acute sodium depletion, up to 450 mmol, was sufficient to increase mean levels of plasma aldosterone from 280 to 500 pmol/l(99-179 ng/l). This increase could be explained on the basis of a reduction in metabolic clearance rate due to dialysis, a possibility that has been stressed by Davis (1972) and again by Weidmann et al. (1973) . Our own work using peritoneal dialysis and shifts in body water of up to nearly 3 1, together with sodium losses of up to 340 mmol, failed to show any rise in plasma aldosterone. If there had been a fall in metabolic clearance rate this in turn would tend to increase plasma aldosterone.
Other workers (Bayard et al., 1971 ; Boyd, Palmore & Mulrow, 1971 ; Weidmann el al., 1972 Weidmann el al., ,1973 have suggested that rises in plasma potassium or changes in intracellular potassium within the zona glomerulosa are responsible for the regulation of aldosterone in the absence of the renin-angiotensin system. The present work showed no clear correlation between resting levels of plasma potassium and aldosterone after nephrectomy (Tables 2, 4 and 7; Fig. 3 ). In fact, some of the highest potassium levels were associated with extremely low levels of plasma aldosterone. However, we made no attempt to study the effect of acute changes in potassium. After bilateral nephrectomy, plasma renin activity is usually very low or undetectable (Weidmann, Maxwell, Lupu, Lewin & Massey, 1971 ) and consequently the renin-angiotensin system would seem to be effectively abolished. Where it was measured in our three patients (M.T., W.H. and B.P.; unpublished data) plasma renin activity fell to very low or undetectable levels. Nevertheless the work of Boyd et al. (1971 ), Weidmann et al. (1972 ), Bayard et al. (1971 ), McCaa et ai. (1972a and Williams et al. (1973) suggests that the adrenal gland is able to increase its output of aldosterone in the absence of the kidney.
There seems to be very little doubt, however, that under normal circumstances the kidney plays a very important role in the regulation of aldosterone secretion. It is probable that the aldosterone response of the zona glomerulosa is under normal circumstances maintained by the kidney and that there may be a time factor involved before this sensitivity can be re-established in nephrectomized man. Most of our patients were studied in the few weeks after nephrectomy whereas much of the recent work was in patients nephrectomized for several months and this may in part explain the rather larger aldosterone responses to various stimuli seen in these studies. However, our one patient (M.T.; see Fig. 1 ) studied closely before and after nephrectomy shows very clearly that the response of the zona glomerulosa diminishes markedly over about 4 weeks. At the same time, no change was seen in the glucocorticoid response of the adrenal. This suggests that, on removal of the kidney, a trophic factor is lost, and that transplanting of a kidney at a later date replaces this factor. The most crucial question to answer, however, if we accept the fact that aldosterone secretion can be stimulated in the absence of the kidney, is how does this come about? In our one patient J.S. (see Tables 4 and 7) , on prolonged haemodialysis, the response to angiotensin and particularly ACTH was considerably more marked than the responses seen in the other patients. This patient unfortunately died from a staphylococcal septicaemia 41 days after transplantation and so an opportunity was available to examine the zona glomerulosa. In many clinical situations where a trophic factor is absent, the end target organ will atrophy. No evidence of atrophy was seen in spite of immunosuppressive therapy with azathioprine and prednisone, but in particular, also, there was no evidence of hypertrophy or an autonomous tumour. This patient's adrenal glands were compared with those of other transplanted patients who had died at about the same time after transplantation and with a number of normal controls. There appeared to be no significant difference (K. A. Porter, personal communication).
An additional factor that should be considered is the effect of heparin administration. Cejka, DeVries, Smorenberg-Schoorl, van Daatselaar, Borst & Majoor (1960) and Schlatmann, Jansen, Prenen, van der Korst & Majoor (1964) first indicated that heparin can suppress aldosterone production and produce a sodium diuresis and potassium retention. We think, however, that it is unlikely that heparin used in such small amounts in peritoneal dialysis would cause suppression of aldosterone secretion. Furthermore, heparin was used both before and after nephrectomy with only a relatively few days between each study. It is unlikely that chronic suppression could have occurred in such a short time and this is supported further by our one patient (J.S.) who had been on haemodialysis for about 8 months and in whom the best responses were seen (Tables 4 and 7 ) . Bayard et al. (1971) also considered the effect of acute heparin administration by infusing heparin for 7 h on a day before dialysis and then measuring aldosterone before and after infusion and on the following morning. There was no evidence of aldosterone suppression.
A possible explanation of our findings is that in normal man angiotensin sensitizes the zona glomerulosa in such a way that other stimuli such as changes in plasma or total body sodium and potassium and ACTH can readily stimulate aldosterone production. Once that particular sensitizing factor is lost, the response of the zona glomerulosa decreases markedly. This does not, however, exclude some other renal-dependent factor. That the adrenal gland is able to produce aldosterone at all, albeit poorly, once the kidney is removed, suggests that such a factor would lie outside the kidney and that its role might be complementary to the presence of an intact kidney. It seems unlikely that ACTH could be such a factor, since the plasma cortisol levels are normal in these nephrectomized patients and the secretion of ACTH therefore may be presumed to be normal. The mainly low resting levels of plasma aldosterone seen are in keeping with the diminished adrenal response to exogenous ACTH in contrast to the normal cortisol responses ( Table 7) .
The recent reports of selective hypoaldosteronism with hyponatraemia, natriuresis, hyperkalaemia and very low plasma levels of angiotensin I1 (Schambelan, Stockigt & Biglieri, 1972; Brown, Chinn, Fraser, Lever, Morton, Robertson, Tree, Waite & Park, 1973) , where in some cases angiotensin infusion restored aldosterone IeveIs and the electrolyte imbalance, suggest a central role for the renin-angiotensin system in the control of aldosterone secretion. Our own evidence, while supporting this, does not exclude an additional kidney-dependent mechanism.
